BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in BioLineRx Ltd. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +2 vs. Q4 2022
- Shares held
- 3.29M
- −2.43M (−42.5%) vs. Q4 2022
- Total value
- $2.91M
- −$455.5K (−13.5%) vs. Q4 2022
- New holders
- 5
- 2 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $206.7K |
| Q1 2026 | 13 | $45.2K |
| Q4 2025 | 14 | $135.6K |
| Q3 2025 | 14 | $104.3K |
| Q2 2025 | 17 | $302.1K |
| Q1 2025 | 12 | $28.0K |
| Q4 2024 | 32 | $435.9K |
| Q3 2024 | 32 | $1.34M |
| Q2 2024 | 31 | $2.42M |
| Q1 2024 | 28 | $1.47M |
| Q4 2023 | 29 | $1.75M |
| Q3 2023 | 29 | $2.46M |
| Q2 2023 | 26 | $1.97M |
| Q1 2023 | 20 | $2.91M |
| Q4 2022 | 18 | $3.37M |
| Q3 2022 | 28 | $10.3M |
| Q2 2022 | 28 | $1.36M |
| Q1 2022 | 26 | $1.99M |
| Q4 2021 | 30 | $5.09M |
| Q3 2021 | 30 | $6.69M |
| Q2 2021 | 30 | $4.01M |
| Q1 2021 | 29 | $13.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ronald Blue Trust, Inc. | 139 | $0 | 0.00% | +139 | New |
| Wells Fargo & Company | 35 | $31 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,053 | $2.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,088 | $2.71K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 4,300 | $3.81K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 14,582 | $12.9K | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 16,000 | $14.2K | 0.00% | 00.0% | Unchanged |
| Cutter & CO Brokerage, Inc. | 16,667 | $14.8K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 20,003 | $17.7K | 0.00% | +20,003 | New |
| Geneos Wealth Management Inc. | 23,500 | $20.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 24,154 | $21.4K | 0.00% | +24,154 | New |
| Advisor Group Holdings, Inc. | 30,953 | $27.4K | 0.00% | +29,747+2,466.6% | Added |
| Geode Capital Management, LLC | 32,026 | $28.1K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 98,916 | $87.7K | 0.00% | +98,916 | New |
| Renaissance Technologies LLC | 106,089 | $94.0K | 0.00% | −151,811−58.9% | Reduced |
| Atria Wealth Solutions, Inc. | 110,366 | $97.8K | 0.00% | −3,000−2.6% | Reduced |
| LPL Financial LLC | 117,710 | $104.3K | 0.00% | 00.0% | Unchanged |
| PVG Asset Management Corp | 128,725 | $114.1K | 0.37% | +128,725 | New |
| Morgan Stanley | 256,912 | $227.8K | 0.00% | +3,960+1.6% | Added |
| Altium Capital Management LP | 2,279,657 | $2.02M | 1.21% | −823,978−26.5% | Reduced |
| Sabby Management, LLC | 0 | $0 | 0.00% | −1,751,992−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,826−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |